Golden
Genentech

Genentech

Biotechnology company that discovers, develops, manufactures and commercializes therapeutic products for serious or life-threatening medical conditions. Disease areas include oncology, immunology, ophthalmology, metabolism and virology. Genentech has been a member of the Roche Group since 2009.

In 2009 Genentech became a member of the Roche Group and the two companies combined their pharmaceutical operations in the US. The San Francisco campus of Genentech serves as headquarters for Roche pharmaceutical operations in the US. Operating as an independent center within Roche is Genentech Research and Early Development.



Genentech was founded by Robert A. Swanson (1947-1999), a venture capitalist, and biochemist Dr. Herbert W. Boyer. Boyer along with Stanley Cohen were pioneers in recombinant DNA technology. 



Genetech has drug manufacturing facilities in South San Francisco, Vacaville and Oceanside, California. Genetech focused on large-scale biologics and products for about 30 years. A shift towards developing therapies that target smaller patient populations began around 2013. Genentech has two commercial large volume products, Herceptin and Rituxan, of which they produce more than 2000 kg per year. The company has six products that classify as standard volume products, between 300 kg and 2000 kg per year, as well as three in clinical trials. As of 2019 Genetech had four products considered small volume, less than 300 kg per year, and nine small volume products in the pipeline. 



Genentech is developing a virtual reality simulator for eye surgery.

Products

Biooncology

Alecensa® (alectinib)

Avastin® (bevacizumab)

Cotellic® (cobimetinib)

Erivedge® (vismodegib)

Gazyva® (obinutuzumab)

Herceptin® (trastuzumab)

Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk)

Kadcyla® (ado-trastuzumab emtansine)

Perjeta® (pertuzumab)

Rituxan® (rituximab [Oncology])

Rituxan Hycela™ (rituximab and hyaluronidase human)

Tarceva® (erlotinib)

Tecentriq® (atezolizumab)

Venclexta® (venetoclax)

Xeloda® (capecitabine)

Zelboraf® (vemurafenib)

Immunology and Ophthalmology

Actemra® (tocilizumab)

Esbriet® (pirfenidone)

Lucentis™ (ranibizumab injection)

Rituxan® (rituximab [Immunology])

Xolair® (omalizumab)

Metabolism and Primary Care

Activase® (alteplase)

Cathflo Activase® (alteplase)

Nutropin AQ® (somatropin (rDNA origin) for injection)

TNKase® (tenecteplase)

Neurology

Ocrevus® (ocrelizumab)

Virology and Specialty Care

CellCept® (mycophenolate mofetil)

Pegasys® (peginterferon alfa-2a)

Pulmozyme® (dornase alfa)

Tamiflu® (oseltamivir phosphate)

Valcyte® (valganciclovir hydrochloride)

Xofluza ™ (baloxavir marboxil)

Other

Boniva Injection® (ibandronate sodium)

Boniva Tablets® (ibandronate sodium)

Cytovene® (ganciclovir)

Fuzeon® (enfuvirtide)

Hemlibra® (emicizumab-kxwh)

Invirase® (saquinavir mesylate)

Klonopin® (clonazepam)

Valium® (diazepam)





Timeline

People

Name
Role
Related Golden topics

aakanksha patel

Employee



Aaron Yip

Employee



Aashima Singhal

Founder



Abraham Gacad

Employee



Adam Tomashek

Employee



Adhithya Mohanraj

Employee



Adilet Matkerimov

Employee



Adrian Jubb

Employee



Adriana Delor

Employee



Ajay Kshatriya

Employee



AKASH ARYA

Employee



Akila Gopalakrishnan

Employee



Akila Subramanian

Employee



Akiyo Marukawa

Previous Employee



Alan C Pikna

Employee



Alan Pruitt

Employee



Alec Howard

Employee



Alefiyah Shambhoora

Employee



Alekhya Akkunuri

Employee



Alex Bash

Employee



Alex Fischer

Employee



Alex Pomerantz

Employee



Alex Smoligovets

Employee



Alexander Kislukhin

Employee



Alexander Kozintsev

Employee



SHOW ALL (671)

Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References